A | B | C | D | E | F | G | H | CH | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9
Identifiers | |
---|---|
| |
PubChem CID | |
DrugBank | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C18H19ClN2 |
Molar mass | 298.81 g·mol−1 |
3D model (JSmol) | |
| |
|
Huprine X is a synthetic cholinergic compound developed as a hybrid between the natural product Huperzine A and the synthetic drug tacrine. It is one of the most potent reversible inhibitors of acetylcholinesterase known, with a binding affinity of 0.026nM,[1] as well as showing direct agonist activity at both nicotinic and muscarinic acetylcholine receptors.[2][3] In animal studies it has nootropic and neuroprotective effects, and is used in research into Alzheimer's disease,[4][5][6][7] and although huprine X itself has not been researched for medical use in humans, a large family of related derivatives have been developed.[8][9][10]
References
- ^ Camps P, Cusack B, Mallender WD, El Achab RE, Morral J, Muñoz-Torrero D, Rosenberry TL (February 2000). "Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease". Molecular Pharmacology. 57 (2): 409–17. PMID 10648652.
- ^ Roman S, Vivas NM, Badia A, Clos MV (June 2002). "Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain". Neuroscience Letters. 325 (2): 103–6. doi:10.1016/s0304-3940(02)00245-8. PMID 12044632. S2CID 30405842.
- ^ Roman S, Badia A, Camps P, Clos MV (January 2004). "Potentiation effects of (+/-)huprine X, a new acetylcholinesterase inhibitor, on nicotinic receptors in rat cortical synaptosomes". Neuropharmacology. 46 (1): 95–102. doi:10.1016/j.neuropharm.2003.08.005. PMID 14654101. S2CID 19189750.
- ^ Ratia M, Giménez-Llort L, Camps P, Muñoz-Torrero D, Clos MV, Badia A (June 2010). "Behavioural effects and regulation of PKCalpha and MAPK by huprine X in middle aged mice". Pharmacology, Biochemistry, and Behavior. 95 (4): 485–93. doi:10.1016/j.pbb.2010.03.013. PMID 20363245. S2CID 34525530.
- ^ Ratia M, Giménez-Llort L, Camps P, Muñoz-Torrero D, Pérez B, Clos MV, Badia A (2013). "Huprine X and huperzine A improve cognition and regulate some neurochemical processes related with Alzheimer's disease in triple transgenic mice (3xTg-AD)". Neuro-Degenerative Diseases. 11 (3): 129–40. doi:10.1159/000336427. PMID 22626981. S2CID 46024586.
- ^ Giménez-Llort L, Ratia M, Pérez B, Camps P, Muñoz-Torrero D, Badia A, Clos MV (April 2017). "Behavioural effects of novel multitarget anticholinesterasic derivatives in Alzheimer's disease". Behavioural Pharmacology. 28 (2 and 3-Spec Issue): 124–131. doi:10.1097/FBP.0000000000000292. PMID 28125507.
- ^ Relat J, Pérez B, Camps P, Muñoz-Torrero D, Badia A, Victòria Clos M (January 2018). "Huprine X Attenuates The Neurotoxicity Induced by Kainic Acid, Especially Brain Inflammation". Basic & Clinical Pharmacology & Toxicology. 122 (1): 94–103. doi:10.1111/bcpt.12852. PMID 28724203.
- ^ Ronco C, Sorin G, Nachon F, Foucault R, Jean L, Romieu A, Renard PY (July 2009). "Synthesis and structure-activity relationship of Huprine derivatives as human acetylcholinesterase inhibitors". Bioorganic & Medicinal Chemistry. 17 (13): 4523–36. doi:10.1016/j.bmc.2009.05.005. PMID 19473849.
- ^ Ronco C, Foucault R, Gillon E, Bohn P, Nachon F, Jean L, Renard PY (May 2011). "New huprine derivatives functionalized at position 9 as highly potent acetylcholinesterase inhibitors". ChemMedChem. 6 (5): 876–88. doi:10.1002/cmdc.201000523. PMID 21344648. S2CID 10893910.
- ^ Galdeano C, Viayna E, Sola I, Formosa X, Camps P, Badia A, et al. (January 2012). "Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases". Journal of Medicinal Chemistry. 55 (2): 661–9. doi:10.1021/jm200840c. PMID 22185619.
Text je dostupný za podmienok Creative Commons Attribution/Share-Alike License 3.0 Unported; prípadne za ďalších podmienok. Podrobnejšie informácie nájdete na stránke Podmienky použitia.
Antropológia
Aplikované vedy
Bibliometria
Dejiny vedy
Encyklopédie
Filozofia vedy
Forenzné vedy
Humanitné vedy
Knižničná veda
Kryogenika
Kryptológia
Kulturológia
Literárna veda
Medzidisciplinárne oblasti
Metódy kvantitatívnej analýzy
Metavedy
Metodika
Text je dostupný za podmienok Creative
Commons Attribution/Share-Alike License 3.0 Unported; prípadne za ďalších
podmienok.
Podrobnejšie informácie nájdete na stránke Podmienky
použitia.
www.astronomia.sk | www.biologia.sk | www.botanika.sk | www.dejiny.sk | www.economy.sk | www.elektrotechnika.sk | www.estetika.sk | www.farmakologia.sk | www.filozofia.sk | Fyzika | www.futurologia.sk | www.genetika.sk | www.chemia.sk | www.lingvistika.sk | www.politologia.sk | www.psychologia.sk | www.sexuologia.sk | www.sociologia.sk | www.veda.sk I www.zoologia.sk